ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
95.69%
Change (1 year)
Categories
Earnings for ADMA Biologics (ADMA)
Earnings in 2023 (TTM): -$3.22 M
According to ADMA Biologics 's latest financial reports the company's current earnings (TTM) are -$3.22 M. In 2022 the company made an earning of -$46.63 M an increase over its 2021 earnings that were of -$58.6 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ADMA Biologics from 2010 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$3.22 M | -93.11% |
| 2022 | -$46.63 M | -20.42% |
| 2021 | -$58.6 M | -8.11% |
| 2020 | -$63.77 M | 62.31% |
| 2019 | -$39.29 M | -34.76% |
| 2018 | -$60.23 M | 48.79% |
| 2017 | -$40.48 M | 134.28% |
| 2016 | -$17.28 M | 7.12% |
| 2015 | -$16.13 M | 0.3% |
| 2014 | -$16.08 M | 7.85% |
| 2013 | -$14.91 M | 71.04% |
| 2012 | -$8.72 M | 28864% |
| 2011 | -$0.04 M | 35.22% |
| 2010 | -$0.03 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $66.08 M | -2,157.38% | 🇺🇸 USA |
 Novavax NVAX | -$0.53 B | 16,357.50% | 🇺🇸 USA |
 Cel-Sci
CVM | -$30.33 M | 844.27% | 🇺🇸 USA |